Showing results (221-230 of 243) with videos related to

Sort By:
Pageof 25
Plos One|September 5, 2018
Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studiesKrista E van Meijgaarden, Bhagwati Khatri, Steven G Smith, et al.
The Journal of Infectious Diseases|September 2, 2011
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and MalawiMaeve K Lalor, Sian Floyd, Patricia Gorak-Stolinska, et al.
Cell Research|March 13, 2019
Vitamin B12 modulates Parkinson's disease LRRK2 kinase activity through allosteric regulation and confers neuroprotectionAdam Schaffner, Xianting Li, Yacob Gomez-Llorente, et al.
Frontiers in Immunology|January 9, 2019
Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis InfectionMatthew K O'Shea, Thomas E Fletcher, Julius Muller, et al.
BMC Infectious Diseases|April 9, 2014
Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UKYun-Gyoung Hur, Patricia Gorak-Stolinska, Maeve K Lalor, et al.
Frontiers in Immunology|August 28, 2020
Mitochondrial Signature in Human Monocytes and Resistance to Infection in C. elegans During Fumarate-Induced Innate Immune TrainingC Angélica Pérez-Hernández, Carina C Kern, Egle Butkeviciute, et al.
Nature Communications|December 7, 2018
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancerJingyi Liu, Zhibing Duan, Weijie Guo, et al.
Molecular Cell|March 7, 2017
Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell DifferentiationKa Lung Cheung, Fan Zhang, Anbalagan Jaganathan, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2022
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil countClaus Bachert, Ana R Sousa, Joseph K Han, et al.
Pageof 25